|Bid||278.74 x 1300|
|Ask||279.36 x 1100|
|Day's Range||277.44 - 288.71|
|52 Week Range||79.22 - 464.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov. 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||332.87|
Dr. Adrian Burrowes, Family Medicine Physician & CFP Physicians Group CEO, joins Yahoo Finance to discuss the latest on the coronavirus pandemic.
Dr. Ben Weston, Milwaukee COVID-19 Emergency Operations Center Medical Director, talks about the process of approving the COVID-19 vaccine for children and the global fight against COVID-19.
Doses expected to be delivered by April 2022 NEW YORK and MAINZ, GERMANY, October 28, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. government has purchased 50 million more doses of the companies’ COVID-19 vaccine. The U.S. will receive these additional doses to continue to support preparedness for pediatric vaccinations, including securing vaccines for children under 5 years of age, should they receive regulatory authorization. The companies expect